In vitro and in vivo advantage of celecoxib surface solid dispersion and dosage form development

Indian Journal of Pharmaceutical Sciences

Volumn 69, Issue 3, 2007, Pages 370-377

  Dixit, R ^a   Nagarsenker, M ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Antiinflammatory activity; Celecoxib; Superdisintegrants; Surface solid dispersion

Indexed keywords

CELECOXIB; DRUG CARRIER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SOLUBILITY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PAW EDEMA; RAT; SOLID STATE; WETTABILITY;

EID: 34548489901     PISSN: 0250474X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0250-474x.34545     Document Type: Article

References (11)

1. Davies NM, McLachlan AJ, Day RO, Williams KM. Clinical pharmacokinetics and pharmacodynamics of celecoxib: A selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet 2000;38:225-42.
2. Paulson SK, Vaughn MB, Jessen SM, Lawal Y, Gresk CJ, Yan B, et al. Pharmacokinetics of celecoxib after oral administration in dogs and humans: Effect of food and site of absorption. J Pharmacol Exp Ther 2001;297:638-45.
3. Seedher N, Bhatia S. Solubility enhancement of Cox-2 inhibitors using various solvent systems. AAPS Pharm SciTech 2003;4:E33.
4. Reddy MN, Rehana T, Ramakrishna S, Chowdary KP, Diwan PV. β-cyclodextrin complexes of celecoxib: Molecular- modeling, characterization, and dissolution studies. AAPS Pharm Sci 2004;6:E7.
5. Nagarsenker MS, Joshi MS. Celecoxib-cyclodextrin systems: Characterization and evaluation of in vitro and in vivo advantage. Drug Develop Ind Pharm 2005;31:169-78.
6. Devi VK, Vijayalakhmi P, Avinash M. Preformulation Studies on Celecoxib with a view to improve bioavailability. Indian J Pharm Sci 2003;65:542-545.
7. Law SL, Chiang CH. Improving dissolution rate of Griseofulvin by deposition on disintegrants. Drug Develop Ind Pharm 1990;16:137-47.
8. Yen SY, Chen CR, Ling MT, Chen L. Investigation of dissolution enhancement of Nifedipine by deposition on the superdiintegrants. Drug Develop Ind Pharm 1997;23:313-7.
9. Barzegar JM, Maleki N, Garjani A, Khandar AA, Haji M, Hosseinloo M, et al. Enhancement of dissolution rate and antiinflammatory effects of Piroxicam using solvent deposition technique. Drug Develop Ind Pharm 2002;28:681-6.
10. Kornblum SS, Stoopak SB. A new tablet disintegrating agent: Cross linked polyvinyl pyrrolidone. J Pharm Sci 1973;62:43-9.
11. Vogel HG, editor. Antiinflammatory activity: Paw edema. Drug discovery and evaluation: pharmacological assays. 2nd ed. Germany; Springer-Verlag Publishers: 1997. p. 759-62.